These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6132473)

  • 41. [Drug treatment of chronic inflammatory diseases of the intestine].
    Modigliani R
    Schweiz Med Wochenschr; 1988 May; 118(20):737. PubMed ID: 2898809
    [No Abstract]   [Full Text] [Related]  

  • 42. [Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature].
    Neĭman KP; Rumiantsev VG
    Eksp Klin Gastroenterol; 2006; (3):56-60. PubMed ID: 17203844
    [No Abstract]   [Full Text] [Related]  

  • 43. [Determination of sulfapyridine levels in serum--a possibility for the control of dose related therapy with sulfasalazine].
    Eitner K; Reinicke C; Hippius M
    Dtsch Z Verdau Stoffwechselkr; 1984; 44(6):282-8. PubMed ID: 6151895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Therapeutic experience with ulcerative colitis and Crohn disease].
    Nagy G; Prónay G; Ujszászy L
    Orv Hetil; 1985 Jan; 126(1):17-20, 23-4. PubMed ID: 2857480
    [No Abstract]   [Full Text] [Related]  

  • 46. New steroids and new salicylates in inflammatory bowel disease: a critical appraisal.
    Campieri M
    Gut; 2002 May; 50 Suppl 3(Suppl 3):III43-6. PubMed ID: 11953332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pancreatitis and pancreatic necrosis during sulfasalazine therapy.
    Faintuch J; Mott CB; Machado MC
    Int Surg; 1985; 70(3):271-2. PubMed ID: 2872181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study.
    Stallmach A; Langbein C; Atreya R; Bruns T; Dignass A; Ende K; Hampe J; Hartmann F; Neurath MF; Maul J; Preiss JC; Schmelz R; Siegmund B; Schulze H; Teich N; von Arnim U; Baumgart DC; Schmidt C
    Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1199-1212. PubMed ID: 27714831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sulfasalazine and new analogues.
    Friedman G
    Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653
    [No Abstract]   [Full Text] [Related]  

  • 50. Antibiotics and inflammatory bowel diseases.
    Gitnick G
    Gastroenterol Clin North Am; 1989 Mar; 18(1):51-6. PubMed ID: 2563991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Infiltration of CD19+ plasma cells with frequent labeling of Ki-67 in corticosteroid-resistant active ulcerative colitis.
    Jinno Y; Ohtani H; Nakamura S; Oki M; Maeda K; Fukushima K; Nagura H; Oshitani N; Matsumoto T; Arakawa T
    Virchows Arch; 2006 Apr; 448(4):412-21. PubMed ID: 16435133
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Eicosanoids in chronic inflammatory intestinal diseases].
    Müller G
    Z Gesamte Inn Med; 1987 Jan; 42(2):37-41. PubMed ID: 2883778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemolysis during salicylazosulfapyridine therapy.
    van Hees PA; van Elferen LW; van Rossum JM; van Tongeren JH
    Am J Gastroenterol; 1978 Nov; 70(5):501-5. PubMed ID: 33552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammatory bowel disease: an uncommon problem in Singapore.
    Tan CC; Kang JY; Guan R; Yap I; Tay HH
    J Gastroenterol Hepatol; 1992; 7(4):360-2. PubMed ID: 1355368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Therapeutic efficacy of 5-ASA molecules in idiopathic intestinal inflammatory diseases: critical review].
    Van Gossum A
    Acta Gastroenterol Belg; 1992; 55(5-6):462-71. PubMed ID: 1363167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Conservative therapy of ulcerative colitis and Crohn disease].
    Rasenack J; Kreisel W
    Fortschr Med; 1991 Apr; 109(11):245-7. PubMed ID: 1855750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inflammatory bowel disease. Part II.
    Hansen R
    Proc Annu Meet Med Sect Am Counc Life Insur; 1978; ():41-9. PubMed ID: 39296
    [No Abstract]   [Full Text] [Related]  

  • 58. Simplified high-performance liquid chromatographic method for 5-aminosalicylic acid in plasma and urine.
    Fischer C; Maier K; Klotz U
    J Chromatogr; 1981 Oct; 225(2):498-503. PubMed ID: 6117565
    [No Abstract]   [Full Text] [Related]  

  • 59. [Chronic regional enterocolitis (Crohn's disease) in juveniles].
    Ehrenpreis T; Gierup J; Lagercrantz R
    Nord Med; 1967 Jan; 77(4):111-6. PubMed ID: 4381124
    [No Abstract]   [Full Text] [Related]  

  • 60. Desensitization of patients with inflammatory bowel disease to sulfasalazine.
    Taffet SL; Das KM
    Am J Med; 1982 Oct; 73(4):520-4. PubMed ID: 6127032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.